Eurazeo (RF) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
24 Jun, 2026Executive summary
Achieved €3.2bn in fundraising over nine months (+4% year-over-year), outpacing a declining global market and gaining market share, driven by private debt and private equity closings, and international expansion.
Assets under management (AUM) rose 5% to €37.4bn, with third-party AUM up 11% to €28.0bn and fee-paying AUM up 7%.
Dynamic asset deployment across business services, AI & tech, environmental solutions, and healthcare, with €3.9bn deployed in 9M 2025.
Realizations totaled €2.2bn for the balance sheet since end 2023, representing 27% of 2023 NAV, with a 2.1x average cash-on-cash multiple and 8% average upside on latest mark.
Shareholder returns enhanced via a €400m buyback program and a 10% dividend increase, with total return initiatives targeting ~€1.0bn by end-2025.
Financial highlights
Management fees reached €316m for the period, with third-party fees up 5% year-over-year; performance fees totaled €10.2m, supported by successful exits.
Deployments totaled €3.9bn, up 20% year-over-year; Q3 private equity deployment at €800m, private debt at €900m.
Portfolio companies showed solid performance: buyout revenues up 6%, growth up 15%, and infrastructure real assets up 24%.
Net value of the balance sheet investment portfolio was €7.4bn as of September 30, 2025.
Realizations in buyouts, venture, and growth included high-profile exits (e.g., CPK, Ultra Premium Direct, Cognigy, ImCheck), often at or above NAV.
Outlook and guidance
Fundraising for FY 2025 expected to exceed €4bn, supported by a strong pipeline and international client expansion.
Guidance for on-balance sheet portfolio value remains between zero and slightly negative for the year, with potential for neutral to slightly positive on a per-share basis due to buybacks.
Expect continued market share gains and strong fundraising in 2026, especially in lower mid-market buyout and infrastructure funds.
Performance fees anticipated to gradually increase, targeting 10% of third-party revenues in the medium term.
Ongoing processes for Q4 2025 expected to further support balance sheet asset rotation.
Latest events from Eurazeo
- Q1 2025 fundraising quadrupled, AUM and shareholder returns rose, and portfolio growth was strong.RF
Q1 202524 Jun 2026 - Strong fundraising, AUM growth, and asset rotation boosted financial position and returns.RF
Q1 202613 May 2026 - AGM approved all resolutions amid strong asset management growth and increased dividends.RF
AGM 202612 May 2026 - Record fundraising and AUM growth drove higher margins and strong shareholder returns.RF
Q4 202511 Mar 2026 - Fundraising and realizations surged, driving growth and enhanced shareholder returns.RF
Q2 20243 Feb 2026 - Fundraising surged 76% to €3bn, AUM and realizations grew, and portfolio performance was strong.RF
Q3 202416 Jan 2026 - Record fundraising and exits drive growth, despite legacy write-downs; shareholder returns surge.RF
Q4 202417 Dec 2025 - All resolutions passed as asset management growth, higher dividends, and strategy advances were confirmed.RF
AGM 202518 Nov 2025 - AUM up 4% to €36.8bn, but net loss widened to -€309m amid fair value and currency headwinds.RF
Q2 20258 Aug 2025